Analysed BICARA THERAPEUTICS INC (BCAX:NASDAQ) News Sources
A Look At Bicara Therapeutics (BCAX) Valuation After Recent Share Price Pullback
19-05-2026
yahoo.com
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
21-05-2026
yahoo.com
Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer
22-05-2026
marketbeat.com
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
13-06-2026
fool.com
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
What is the current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ) is $24.58.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is $1.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is 4.2409%.
What is the most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is .
SEC-8K** Filing Available For BICARA THERAPEUTICS INC (BCAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.